We sell in-depth short-selling reports for any company ₿ 0.10 BTC.
Contact us today.
Short Interest Update USOKUR

OnKure Therapeutics (OKUR) Short Interest Update

OnKure Therapeutics shows a steady increase in short interest with 1.4 million shares currently sold short and a days-to-cover ratio of 9.3.

Powered by NegativePublicRelations.com
By The Forensic Ledger Desk October 7, 20261 min read
Company
OnKure Therapeutics, Inc.
Borrow Fee
1.4%
Short % Float
0%
Days to Cover
9.3

Current Short Position Analysis

OnKure Therapeutics, Inc. (NASDAQ: OKUR) is currently seeing significant short interest activity. As of the latest data, the company has 1.4 million shares sold short. With a days-to-cover ratio of 9.3, the stock exhibits a moderate level of short-side positioning that warrants attention from market participants. The borrow fee for the security is currently holding at 1.4% as of October 7, 2026.

Market Context

This data reflects a period of increased scrutiny for the pharmaceutical firm, which has seen its shares outstanding grow by 21% over the last two years. While the borrow fee remains relatively low, the elevated days-to-cover suggests that any sudden shift in sentiment or positive clinical news could lead to a rapid unwinding of these positions. Investors should monitor the borrow fee for any sudden spikes, which would indicate a tightening of share availability.

Source

Signal data sourced from CurvedTrading. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Biotech#Short Interest#Nasdaq

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets. Costs: ₿ 0.10 BTC

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog
Contact Us on Telegram